Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-09-12

Clinical Trial Update: Effect of L-Thyroxine on Lipid Profiles and Atherosclerosis in Subclinical Hypothyroidism [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the effect of L-Thyroxine on lipid profiles and atherosclerosis in subclinical hypothyroidism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-Thyroxine (levothyroxine)

Snippet

Sponsor: Shandong Provincial Hospital | Conditions: Hypothyroidism, Thyroid Diseases | Phase 4 | Status: UNKNOWN